Chelation Vindicated for CVD Risk Reduction in Diabetes
New data from the NIH-funded Trial to Assess Chelation Therapy (TACT), has vindicated this controversial treatment as a method for preventing cardiovascular events in people with diabetes. The data show a clear 15% reduction in index events among treated patients.